D'AMBROSIO, LUIGI
 Distribuzione geografica
Continente #
AS - Asia 119
NA - Nord America 115
EU - Europa 107
SA - Sud America 15
AF - Africa 2
Totale 358
Nazione #
US - Stati Uniti d'America 112
SG - Singapore 64
RU - Federazione Russa 49
CN - Cina 33
IT - Italia 26
DE - Germania 16
BR - Brasile 13
HK - Hong Kong 8
FR - Francia 5
VN - Vietnam 5
FI - Finlandia 4
GB - Regno Unito 3
IE - Irlanda 3
CA - Canada 2
IN - India 2
AR - Argentina 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CL - Cile 1
EG - Egitto 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
SE - Svezia 1
TW - Taiwan 1
Totale 358
Città #
Singapore 29
Chandler 25
Beijing 19
Moscow 10
Munich 9
Hong Kong 8
Santa Clara 8
Rome 7
Ashburn 5
Millbury 5
Falkenstein 3
Helsinki 3
Houston 3
Nanjing 3
Naples 3
Seattle 3
Boston 2
Buffalo 2
Changsha 2
Chicago 2
Des Moines 2
Fisciano 2
Hanoi 2
Ho Chi Minh City 2
Lauterbourg 2
Lawrence 2
Los Angeles 2
Nanchang 2
New York 2
Norwalk 2
Princeton 2
Redondo Beach 2
São Paulo 2
Wilmington 2
Apo 1
Baku 1
Bexley 1
Braço do Norte 1
Cairo 1
Canoas 1
Caxias do Sul 1
Colatina 1
Costa di Mezzate 1
Crystal Lake 1
Dublin 1
Düsseldorf 1
Fairfield 1
Florianópolis 1
Frankfurt am Main 1
Goiânia 1
Guiyang 1
Indianapolis 1
Jayapura 1
Kuala Lumpur 1
London 1
Ludhiana 1
Manhuaçu 1
Mexico City 1
Milan 1
Moreno Valley 1
Muscat 1
Napoli 1
Nuremberg 1
Orem 1
Ottawa 1
Peruíbe 1
Phoenix 1
Portici 1
Punta Arenas 1
Redwood City 1
Rio de Janeiro 1
San Francisco 1
San Miguel de Tucumán 1
Santa Luzia 1
Sialkot 1
Stockholm 1
Taipei 1
Tokyo 1
Toronto 1
Trento 1
Turku 1
Utica 1
Volta Redonda 1
Yablonovsky 1
Totale 229
Nome #
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 99
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 96
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 88
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 87
Totale 370
Categoria #
all - tutte 1.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 3 0 0
2021/202225 1 0 0 0 0 1 1 3 3 2 4 10
2022/202340 5 10 1 1 5 4 0 8 1 0 2 3
2023/202417 3 5 1 3 0 0 0 1 0 0 2 2
2024/2025118 3 5 0 0 3 10 10 11 5 14 43 14
2025/2026114 23 15 22 9 39 6 0 0 0 0 0 0
Totale 370